Apotex Research

Walk in interview in Production, Regulatory Affairs, Product Development at Apotex Research

Apotex Research Pvt. Ltd. is a wholly owned subsidiary of Apotex Inc. Canada which is a number one generic pharma co. in Canada. The position is for Bangalore location which has an R&D Centre, Manufacturing and a Bioequivalence Centre.

Post: Manager, Pharmacist, Team Leader, Technicians, Research Scientist

Job as Team Leader-Quality R&D in Pharmaceutical Company in Apotex Research

Apotex Inc., founded in 1974, is the largest Canadian-owned pharmaceutical company. We employ over 6,000 people worldwide in research, development, manufacturing, and distribution. We produce more than 300 generic pharmaceuticals in approximately 4,000 dosages and formats and export to over 115 countries around the globe.

Post: Team Leader-Quality R&D in Pharmaceutical Company

Walk in Interview for Manufacturing Operations as Production Technician, Production - Team Leader / Senior Pharmacist/ Pharmacist @ Apotex - Freshers may mail their CVs

Apotex Inc., founded in 1974, is the largest Canadian-owned pharmaceutical company. We employ over 6,000 people worldwide in research, development, manufacturing and distribution. We produce more than 300 generic pharmaceuticals in approximately 4000 dosages and formats a nd export to over 115 countries around the globe.
APOTEX RESEARCH PRIVATE LIMITED (ARPL) based at Bangalore is engaged in the development, bio-clinical evaluation, manufacturing and distribution of safe and efficacious generic pharmaceutical formulations for the global market

Farewell time for world’s largest selling chartbuster pharmaceutical brand Lipitor®: What next after November 30, 2011

About Authors:
Dr. Amit Gangwal,
Smriti College of Pharmaceutical Education,
Indore

Introduction
Lipitor® is the best-selling drug ever, accounting for $106 billion sales over the last decade. Two generic drug manufacturers are ready to compete starting December 1, 2011. Watson Pharmaceuticals is making a generic version authorized by Pfizer under a profit-sharing agreement. Pending federal approval, Ranbaxy Laboratories also plans to sell a generic version. It is noteworthy that when a drug’s patent protection expires, the federal law permits only limited generic competition in the first six months1.

Pages